By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


ViiV Healthcare 

Five Moore Drive

Research Triangle Park  North Carolina  27709-3398  U.S.A.
Phone: 877-844-8872 Fax: n/a


Company News
ViiV Healthcare, Medicines Patent Pool Extend Licence For Dolutegravir To All Lower Middle-Income Countries 4/25/2016 7:25:58 AM
ViiV Healthcare Announces First Phase II HIV Prevention Study Results for Investigational Long-acting Injectable Cabotegravir 2/25/2016 6:06:48 AM
ViiV Healthcare Announces Phase II Study Results For First Two Drug, Long-Acting Injectable Regimen For HIV-1 Treatment 2/24/2016 6:35:03 AM
Bristol-Myers Squibb (BMY) Completes Previously Announced Sale Of Its HIV R&D Portfolio To ViiV Healthcare 2/22/2016 12:09:03 PM
GlaxoSmithKline (GSK)'s Global HIV Business ViiV Healthcare Completes Transactions To Acquire Bristol-Myers Squibb (BMY)'s R&D HIV Assets 2/22/2016 10:26:00 AM
ViiV Healthcare To Progress Collaboration With Janssen To Develop The First Long-Acting, Two Drug Injectable Regimen For Treatment Of HIV-1 Infection 1/7/2016 6:55:21 AM
ViiV Healthcare Awards Additional Round Of Grants To Support Innovative HIV Programs Aimed At Reducing Disparities In The Southern U.S. 11/20/2015 9:44:45 AM
ViiV Healthcare Hitting Hard But Gilead (GILD) Management is Well-Prepared 11/3/2015 7:08:09 AM
ViiV Healthcare Announces Positive Headline Results From A Study Of Two Drug Injectable Regimen For HIV Maintenance Therapy 11/3/2015 6:52:02 AM
ViiV Healthcare Awards Innovative Grants For HIV Programs Focused On MSM Youth 11/2/2015 10:56:08 AM